Clinical features of vascular disorders associated with chronic hepatitis virus infection

Digestive Diseases

Volumn 32, Issue 6, 2014, Pages 786-790

  Nishida, Naoshi ^a   Kudo, Masatoshi ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cryoglobulinemia; Nephropathy; Polyarteritis nodosa; Vascular disorders; Viral hepatitis

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ANTIVIRAL THERAPY; CHRONIC HEPATITIS; CLINICAL FEATURE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; NONHUMAN; PLASMAPHERESIS; POLYARTERITIS NODOSA; PROGNOSIS; VASCULAR DISEASE; VIRUS HEPATITIS; COMORBIDITY; FEMALE; KIDNEY DISEASES; MALE; PREVALENCE; VASCULAR DISEASES;

COMORBIDITY; CRYOGLOBULINEMIA; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; KIDNEY DISEASES; MALE; POLYARTERITIS NODOSA; PREVALENCE; PROGNOSIS; VASCULAR DISEASES;

EID: 84910676324     PISSN: 02572753     EISSN: 14219875     Source Type: Journal    
DOI: 10.1159/000368023     Document Type: Conference Paper

References (30)

1. Kim Do Y, Han KH: Epidemiology and surveillance of hepatocellular carcinoma. Liver Cancer 2012;1:2-14.
2. Kawanaka M, Nishino K, Nakamura J, Oka T, Urata N, Goto D, Suehiro M, Kawamoto H, Kudo M, Yamada G: Quantitative levels of hepatitis B virus DNA and surface antigen and the risk of hepatocellular carcinoma in patients with hepatitis B receiving long-term nucleos (t) ide analogue therapy. Liver Cancer 2014;3:41-52.
3. Han SH: Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 2004;8:403-418.
4. Himoto T, Masaki T: Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection. Clin Dev Immunol 2012;2012:871401.
5. Nishida N: Vasculitis associated with hepatitis virus. J Clin Exp Med (Igaku no Ayumi) 2013;246:127-130.
6. Saadoun D, Rosenzwajg M, Joly F, Six A, Carrat F, Thibault V, Sene D, Cacoub P, Klatzmann D: Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis. N Engl J Med 2011;365:2067-2077.
7. Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL: Association between polyarteritis and Australia antigen. Lancet 1970;2:1149-1153.
8. Pyrsopoulos NT, Reddy KR: Extrahepatic manifestations of chronic viral hepatitis. Curr Gastroenterol Rep 2001;3:71-78.
9. Ramos-Casals M, Stone JH, Cid MC, Bosch X: The cryoglobulinaemias. Lancet 2012;379:348-360.
10. Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC: Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977;296:1501-1504.
11. Trejo O, Ramos-Casals M, Garcia-Carrasco M, Yague J, Jimenez S, De La Red G, Cervera R, Font J, Ingelmo M: Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine 2001;80:252-262.
12. Mathieu E, Fain O, Krivitzky A: Cryoglobulinemia after hepatitis B vaccination. N Engl J Med 1996;335:355.
13. Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin EC: Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.
14. Saadoun D, Asselah T, Resche-Rigon M, Charlotte F, Bedossa P, Valla D, Piette JC, Marcellin P, Cacoub P: Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 2006;43:1337-1345.
15. Rosa D, Saletti G, De Gregorio E, Zorat F, Comar C, D'Oro U, Nuti S, Houghton M, Barnaba V, Pozzato G, Abrignani S: Activation of naive B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders. Proc Natl Acad Sci USA 2005;102:18544-18549.
16. Knight GB, Gao L, Gragnani L, Elfahal MM, De Rosa FG, Gordon FD, Agnello V: Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies. Arthritis Rheum 2010;62:2152-2159.
17. Saadoun D, Resche Rigon M, Sene D, Terrier B, Karras A, Perard L, Schoindre Y, Coppere B, Blanc F, Musset L, Piette JC, Rosenzwajg M, Cacoub P: Rituximab plus Peg-interferon-alpha/ribavirin compared with Peg-interferonalpha/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 2010;116:326-334; quiz 504-505.
18. Trepo C, Guillevin L: Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 2001;16:269-274.
19. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, Noel LH, Trepo C: Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine 1995;74:238-253.
20. Wartelle-Bladou C, Lafon J, Trepo C, Pichoud C, Picon M, Pellissier JF, Zoulim F: Successful combination therapy of polyarteritis nodosa associated with a pre-core promoter mutant hepatitis B virus infection. J Hepatol 2001;34:774-779.
21. Guillevin L, Mahr A, Cohen P, Larroche C, Queyrel V, Loustaud-Ratti V, Imbert B, Hausfater P, Roudier J, Bielefeld P, Petitjean P, Smadja D: Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 2004;51:482-487.
22. Locasciulli A, Testa M, Valsecchi MG, Bacigalupo A, Solinas S, Tomas JF, Ljungman P, Alberti A: The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group. Transplantation 1999;68:1486-1491.
23. Combes B, Shorey J, Barrera A, Stastny P, Eigenbrodt EH, Hull AR, Carter NW: Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 1971;2:234-237.
24. Li P, Wei RB, Tang L, Wu J, Zhang XG, Chen XM: Clinical and pathological analysis of hepatitis B virus-related membranous nephropathy and idiopathic membranous nephropathy. Clin Nephrol 2012;78:456-464.
25. Takekoshi Y, Tanaka M, Miyakawa Y, Yoshizawa H, Takahashi K, Mayumi M: Free 'small' and IgG-associated 'large' hepatitis B e antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Engl J Med 1979;300:814-819.
26. Chadban SJ, Atkins RC: Glomerulonephritis. Lancet 2005;365:1797-1806.
27. Tang S, Lai FM, Lui YH, Tang CS, Kung NN, Ho YW, Chan KW, Leung JC, Lai KN: Lamivudine in hepatitis B-associated membranous nephropathy. Kidney Int 2005;68:1750-1758.
28. Lai CL, Yuen MF: Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy. Hepatology 2013;57:399-408.
29. Manns MP, Rambusch EG: Autoimmunity and extrahepatic manifestations in hepatitis C virus infection. J Hepatol 1999;31(suppl 1):39-42.
30. Ohta S, Yokoyama H, Furuichi K, Segawa C, Hisada Y, Wada T, Takasawa K, Kobayashi K: Clinicopathologic features of glomerular lesions associated with hepatitis C virus infection in Japan. Clin Exp Nephrol 1997;1:216-224.